There is currently no scientific evidence to suggest that the efficacy of Cosentyx (secukinumab) is influenced by vaccine intake. Cosentyx is a medication used to treat a number of autoimmune diseases, including psoriasis, psoriatic arthritis, and ankylosing spondylitis. It works by blocking the action of a specific protein involved in inflammation, called interleukin-17A [1].

Vaccines, on the other hand, work by stimulating the immune system to produce a response to a specific antigen. This response involves the production of antibodies and the activation of immune cells, which can then recognize and attack the antigen if it is encountered again in the future [2].

While there is some evidence to suggest that certain medications, such as immunosuppressants, can affect the immune response to vaccines, there is no specific information available regarding the interaction between Cosentyx and vaccines [3]. It is always important to discuss any concerns about medication interactions with a healthcare provider.

In summary, based on the available information, there is no evidence to suggest that Cosentyx efficacy is influenced by vaccine intake. However, it is always important to consult with a healthcare provider regarding any concerns about medication interactions.

Sources:

1. Cosentyx (secukinumab) [prescribing information]. Novartis Pharmaceuticals Corporation; 2021. Available at: <https://www.novartis.us/sites/www.novartis.us/files/cosentyx.pdf>.
2. Centers for Disease Control and Prevention. How vaccines work. <https://www.cdc.gov/vaccines/vac-gen/howvaccineswork.htm>.
3. DrugPatentWatch. Secukinumab. <https://www.drugpatentwatch.com/drugs/secukinumab>.